Based on the tenets of self-determination theory, the present studies examined the moderating effects of interpersonal contexts or goal conditions that afforded satisfaction of psychological needs on loss aversion effects. We hypothesized that behavioural responses to small losses would be stronger relative to behavioural responses to small gains under goal conditions or interpersonal contexts that did not support psychological needs. We also expected the effect to be minimized under goal conditions or interpersonal contexts that supported psychological needs. This prediction was supported in Study 1 that induced satisfaction of psychological needs via manipulations of interpersonal context and in Study 2 that instigated satisfaction of psychological needs via manipulations of goal contents. In addition, Studies 1 and 2 demonstrated that psychological needs reduced the classic loss aversion effect by increasing behavioural and affective responses to gains and not because psychological needs altered affective or behavioural responses to losses. Results of the present studies support the conclusion that contextual autonomy support and the distinction between intrinsic and extrinsic goals proposed by self-determination theory define a boundary condition of the loss aversion hypothesis.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.2044-8309.2011.02033.xDOI Listing

Publication Analysis

Top Keywords

behavioural responses
16
small losses
12
small gains
12
responses small
12
interpersonal contexts
12
goal conditions
12
satisfaction psychological
12
loss aversion
12
contextual autonomy
8
autonomy support
8

Similar Publications

Introduction: Varenicline is an α4β2 nicotinic acetylcholine receptor partial agonist with the highest therapeutic efficacy of any pharmacological smoking cessation aid and a 12-month cessation rate of 26%. Genetic variation may be associated with varenicline response, but to date no genome-wide association studies of varenicline response have been published.

Methods: In this study, we investigated the genetic contribution to varenicline effectiveness using two electronic health record-derived phenotypes.

View Article and Find Full Text PDF

The Association Between Dietary Supplement Use and COVID-19 Symptoms.

J Diet Suppl

January 2025

Department of Epidemiology, Fay W. Boozman College of Public Health, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.

The scientific evidence supporting recommendations for dietary supplement use to prevent or treat coronavirus disease 2019 (COVID‑19) is not well‑established. This cohort study investigates the relationship between dietary supplement usage and COVID‑19 symptoms among 27,181 adults tested for COVID‑19. Using data from surveys following COVID‑19 testing, conducted by the University of Arkansas for Medical Sciences, associations between dietary supplement usage, symptomatology, and COVID‑19 status were explored.

View Article and Find Full Text PDF

Proteomic patterns associated with ketamine response in major depressive disorders.

Cell Biol Toxicol

January 2025

Research Institute, The Affiliated Brain Hospital, Guangzhou Medical University, Guangzhou, 510370, China.

Background: Major depressive disorder (MDD) is characterized by persistent feelings of sadness and loss of interest. Ketamine has been widely used to treat MDD owing to its rapid effect in relieving depressive symptoms. Importantly, not all patients respond to ketamine treatment.

View Article and Find Full Text PDF

Carbene-metal-amide (CMA) complexes have diverse applications in luminescence, imaging and sensing. In this study, we designed and synthesized a series of CMA complexes, which were subsequently doped into a PMMA host. These materials demonstrate light-induced dynamic phosphorescence, attributed to their long intrinsic triplet state lifetime (τP,int, in the μs-ms scale), high intersystem crossing (ISC) rate constant (kISC, up to 107 s-1), and bright phosphorescence.

View Article and Find Full Text PDF

Safer chemical alternatives to bisphenol (BP) have been a major pursuit of modern green chemistry and toxicology. Using a chemical similarity-based approach, it is difficult to identify minor structural differences that contribute to the significant changes of toxicity. Here, we used omics and computational toxicology to identify chemical features associated with BP analogue-induced embryonic toxicity, offering valuable insights to inform the design of safer chemical alternatives.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!